HGF/c-MET signaling is involved in the metabolic reprogramming of tumor cells in head and neck squamous cell carcinoma regulating cell proliferation and invasion capabilities and affecting immune surveillance and activation in the tumor microenvironment (27, 28). This evidence concerns the gene MET and head and neck squamous cell carcinoma.